Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Slides:

Advertisements

Similar presentations

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:

Advertisements

Ethnic differences in risks and explanations for the cardiometabolic syndrome in the UK Nish Chaturvedi Professor of Clinical Epidemiology Imperial College.

Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.

High-density lipoprotein subclasses in subjects with impaired fasting glucose Filippatos TD 1, Barkas F 1, Klouras E 1, Liontos A 1, Rizos EC 1, Gazi I.

SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.

Key messages Stephen S Lim, et al. Lancet 2007; 370:

CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.

Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care

NHANES III Prevalence of Hypertension* According to BMI

PEEHIP Wellness Program New and Enhanced!. PEEHIP Wellness Program  Fact: According to the US Department of Health and Human Services, chronic diseases.

BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:

LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]

Non-diabetes 64.7% Diabetes 35.3% Diagnosed diabetes 5.6% Pre-diabetes 26.0% Undiagnosed diabetes 2.8% Age-adjusted diabetes prevalence among Alaska adults,

Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.

Coronary Artery Disease  Coronary artery disease is one of the most common and serious effects of aging. Fatty deposits build up in blood vessel walls.

EURObservational Research Programme

Diabetes National Diabetes Control Programme

High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.

To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.

Health Examination Surveys in Europe Hanna Tolonen National Public Health Institute, Finland.

Lesotho STEPS Survey 2012 Fact Sheet John Nkonyana Director Disease Control.

Age Adjusted Prevalence of Hypertension* Among Adults by Education in NYC, 2004 Data from: New York City Department of Health and Mental Hygiene, EpiQuery.

Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council

Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council

NHS Health Checks Helping you prevent heart disease, stroke, diabetes and kidney disease.

Ridker PM, et al. Lancet 2009;373: Baseline clinical characteristics of the study population in the placebo and rosuvastatin groups according.

NS 210: Seminar 8 Nutritional Assessment in Disease Prevention.

Results of 12 month follow up in Tulppa outpatient rehabilitation program.

Cholesterol-lowering effects of a stanol- ester containing low-fat margarine used in conjunction with a strict lipid-lowering diet Andersson A et al. Eur.

R ESULTS W ORLD K IDNEY D AY: F IVE Y EAR A NALYSIS OF H EALTH A WARENESS E VENTS IN UK Shah S 1, Agarwal K 1, Nelapatla R 1, Pandya B 1,2 1 Faculty of.

Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.

Presented by Slyter Nutrition Consulting Services.

Baseline characteristics of HPS participants by prior cerebrovascular disease.

Category Sex Systolic BP (mmHg) Men (n=58) Women (n=106) P value

Lacto-ovo vegetarian group

Alcohol, Other Drugs, and Health: Current Evidence July–August 2017

Chapter 4 Where Are You.

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

From ESH 2016 | LB 3: Davide Agnoletti, MD

Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,

All-cause mortality by treatment group

Copyright © 2007 American Medical Association. All rights reserved.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

Prevalence and control of cardiovascular risk factors using a German sample – Findings from the STAAB Cohort Study Theresa Tiffe1,3, Götz Gelbrich1,2,

Copyright © 2012 American Medical Association. All rights reserved.

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.

Cardiometabolic Health Check

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

The percentage of subjects with de novo development of renal function impairment (GFR

Figure 5 Risk factor control in the intensive treatment group

Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53

Description of studies for pooled analyses

Volume 379, Issue 9822, Pages (March 2012)

Level of risk factor control in the overall sample and by gender

Reasons patients were excluded from the switch from atorvastatin to simvastatin J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23.

Volume 379, Issue 9822, Pages (March 2012)

Baseline Characteristics of the Subjects*

Kotseva K, et al. Lancet 2009;373:929-40

RECORD Study: Enrollment and Outcomes

Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Associations of body mass index (BMI) levels with achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in the upper panels.

Number of antihypertensive agents prescribed for known nephropaths in phases I and II (▪), with blood pressure recordings falling outside guidelines, compared.

ROC curves for cardiovascular events, all-cause mortality, and disease progression. ROC curves for cardiovascular events, all-cause mortality, and disease.

HR for mortality in ischemic heart disease.

HR for myocardial infarction.

Adjusted HRs for death from any cause and death from specific causes among patients with type 1 diabetes. Adjusted HRs for death from any cause and death.

Presentation transcript:

Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Participating countries and centres Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Study population (number) enrolled from medical records and patient interviews by country, sex, age and diagnostic categories Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Available information (%) on coronary risk factors and measurements of weight, height, waist, blood pressure, lipids, glucose and HbA1c in hospital discharge documents, by country, sex, age and diagnostic category Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Reported lifestyle changes since the index event (%) taken by patients to reduce their risk of heart disease by country, age, sex and diagnostic category Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Quantitative coronary heart disease risk factors at interview, by country, age and diagnostic category Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Prevalence (%) of coronary heart disease risk factors at interview, by country, age and diagnostic category Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Therapeutic control of blood pressure and serum cholesterol at interview, by centre and diagnostic category; goal for blood pressure: systolic blood pressure <140 and diastolic BP <90mmHg (<130/80mmHg in patients with diabetes); goal for cholesterol: serum total cholesterol < 4.5 mmol/l Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Glycaemic control among patients with self-reported diabetes Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Reported medication (%) at the time of interview (I), and recorded medication in the medical records at discharge (D) and interview, of those interviewed, by country, age and diagnostic category Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]